|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands
2 Eijkman-Winkler Institute, Department of Virology, University Medical Center, Utrecht, The Netherlands
3 Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands
4 Department of Biochemistry and Molecular Biology, University of Tokyo, Tokyo, Japan
5 CREST of Japan Science and Technology Corporation, Tokyo, Japan
6 Department of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands
7 Department of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands
8 Laboratory of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
* To whom correspondence should be addressed. E-mail: kvandersluijs{at}amc.uva.nl.
Although influenza infection alone may lead to pneumonia, secondary bacterial infections are a much more common cause of pneumonia. Streptococcus (S.) pneumoniae is the most frequently isolated causative pathogen during postinfluenza pneumonia. Considering that S. pneumoniae utilizes the platelet-activating factor receptor (PAFR) to invade the respiratory epithelium and that the PAFR is upregulated during viral infection, we here used PAFR gene deficient (PAFR-/-) mice to determine the role of this receptor during postinfluenza pneumococcal pneumonia. Viral clearance was similar in wildtype and PAFR-/- mice and influenza virus was completely removed from the lungs at the time mice were inoculated with S. pneumoniae(day 14 after influenza infection). PAFR-/- mice displayed a significantly reduced bacterial outgrowth in their lungs, a diminished dissemination of the infection and a prolonged survival. Pulmonary levels of IL-10 and KC were significantly lower in PAFR-/- mice, whereas IL-6 and TNF-
were only trendwise lower. These data indicate that the pneumococcus uses the PAFR leading to severe pneumonia in a host previously exposed to influenza A.
This article has been cited by other articles:
![]() |
J. M. Nicholls, L. M. Aschenbrenner, J. C. Paulson, E. R. Campbell, M. P. Malakhov, D. F. Wurtman, M. Yu, and F. Fang Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza J. Antimicrob. Chemother., August 1, 2008; 62(2): 426 - 428. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |